Nigeria: Zrosk IM acquires stake in MeCure Industries
Summary
** For the best experience, download the free Africa Private Equity News app Android | iOS **The transaction, which was conducted off-market, has been finalised following approval from the Nigerian Exchange Group (NGX).Commenting on the acquisition, Arjun Udani, co-CEO of MeCure Industries, stated: "We are delighted to welcome Zrosk Investment Management as a key shareholder in MeCure. This investment reflects the confidence in our long-term growth strategy and our commitment to delivering quality healthcare solutions to millions of Nigerians. With Zrosks support, we are well-positioned to execute our ambitious expansion plans and continue making a positive impact on the healthcare sector in Nigeria and beyond. We view the stock market as a theatre of such transition, and we see MeCure Industries as a potential dominant player in the pharmaceutical value chain on the continent. From our analysis, MeCure Industries can deliver products in critical therapeutic areas at a unit cost that helps drive affordability across the population.